Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Redd

Showing results (91-100 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Infectious Diseases|April 2, 2026
Pre-ART Vertical HIV-1 Transmission Risk in Uganda Varies by Sex of Child and Maternal Viral SubtypeZoe Gotthold, Adam Epstein-Shuman, Godfrey Kigozi, et al.
The Journal of Infectious Diseases|November 30, 2017
Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, UgandaDenali Boon, Andrew D Redd, Oliver Laeyendecker, et al.
Journal of Clinical Microbiology|June 24, 2011
Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencingAndrew D Redd, Aleisha Collinson-Streng, Craig Martens, et al.
Journal of Infection and Public Health|March 14, 2025
Autoantibodies to interferon alpha, nuclear antigens, cardiolipin, and beta 2 glycoprotein 1 in a Ugandan cohort and their relation to SARS-CoV-2 infectionAdam Epstein-Shuman, Xianming Zhu, Joanne H Hunt, et al.
AIDS Research and Human Retroviruses|September 10, 2011
HIV type 1 genetic variation in foreskin and blood from subjects in Rakai, UgandaRonald M Galiwango, Susanna L Lamers, Andrew D Redd, et al.
Nature Communications|August 24, 2023
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populationsAndrew P Hederman, Harini Natarajan, Leo Heyndrickx, et al.
Transfusion|October 21, 2022
Absence of pathogenic viruses in COVID-19 convalescent plasmaAbraham J Kandathil, Sarah E Benner, Evan M Bloch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2017
Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, UgandaJessica L Prodger, Jun Lai, Steven J Reynolds, et al.
Journal of Clinical Microbiology|June 30, 2017
Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive PatientsAubin J Nanfack, Andrew D Redd, Jude S Bimela, et al.
The Journal of Infectious Diseases|August 8, 2013
HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progressionOon Tek Ng, Oliver Laeyendecker, Andrew D Redd, et al.
Pageof 18

Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|April 2, 2026
Pre-ART Vertical HIV-1 Transmission Risk in Uganda Varies by Sex of Child and Maternal Viral SubtypeZoe Gotthold, Adam Epstein-Shuman, Godfrey Kigozi, et al.
The Journal of Infectious Diseases|November 30, 2017
Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, UgandaDenali Boon, Andrew D Redd, Oliver Laeyendecker, et al.
Journal of Clinical Microbiology|June 24, 2011
Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencingAndrew D Redd, Aleisha Collinson-Streng, Craig Martens, et al.
Journal of Infection and Public Health|March 14, 2025
Autoantibodies to interferon alpha, nuclear antigens, cardiolipin, and beta 2 glycoprotein 1 in a Ugandan cohort and their relation to SARS-CoV-2 infectionAdam Epstein-Shuman, Xianming Zhu, Joanne H Hunt, et al.
AIDS Research and Human Retroviruses|September 10, 2011
HIV type 1 genetic variation in foreskin and blood from subjects in Rakai, UgandaRonald M Galiwango, Susanna L Lamers, Andrew D Redd, et al.
Nature Communications|August 24, 2023
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populationsAndrew P Hederman, Harini Natarajan, Leo Heyndrickx, et al.
Transfusion|October 21, 2022
Absence of pathogenic viruses in COVID-19 convalescent plasmaAbraham J Kandathil, Sarah E Benner, Evan M Bloch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2017
Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, UgandaJessica L Prodger, Jun Lai, Steven J Reynolds, et al.
Journal of Clinical Microbiology|June 30, 2017
Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive PatientsAubin J Nanfack, Andrew D Redd, Jude S Bimela, et al.
The Journal of Infectious Diseases|August 8, 2013
HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progressionOon Tek Ng, Oliver Laeyendecker, Andrew D Redd, et al.
Pageof 18